All News

The Agency for Healthcare Research and Quality (AHRQ) is a comparatively small part of the federal budget, but its research priorities for FY 2016 affect areas that consume huge sums.

A study published in the Journal of Thoracic Disease digs deep into understanding the assumptions in HEOR studies that evaluate the cost-effectiveness of personalized cancer treatments.

Amid President Barack Obama's planned Precision Medicine Initiative, the FDA is evaluating its regulatory approach to next-generation sequencing.

More than 400,000 Medicare beneficiaries who may have been confused or misinformed about the pharmacy details of their 2015 Aetna prescription drug plans have until the end of this month to find participating pharmacies or switch plans, according to CMS.

The report, sponsored by the Patient-Centered Primary Care Collaborative, reviewed 28 studies of PCMHs over a 1 year period; some of the studies found improved utilization resulted in an improvement in at least 1 cost metric.

Putting data in patient hands, the construction of an open API, and interoperability are big hopes for the future of health information technology (IT), according to panelists at the annual meeting of the Office of the national Coordinator for Health IT.

Panelists discuss ways to improve the focus on clinical utility in molecular diagnostics given challenges in the system and needs of patients.

The President's budget proposal for 2016 seeks to gain the ability to negotiate drug prices under Medicare Part D, which will definitely face resistance from the Republican-controlled Congress.

Health information technology (IT) can create greater healthcare disparities if all patient groups and their concerns aren't considered properly, panelists said on the first day of the annual meeting of the Office of the National Coordinator for Health IT.

The dual inhibitor tablet, a combination of an SGLT-2 inhibitor and a DPP-4 inhibitor, is expected to stimulate the pancreas to produce more insulin and stimulate the liver to produce less glucose, and also prevent glucose reabsorption.

Although estimates suggest more than 8% in the state suffer from diabetes, federal budge cuts have been partly responsible for the lack of funding.

Governor John Kasich changed eligibility rules to add 450,000 Ohioans to Medicaid last year. The budget he presents to the Legislature will be silent on reauthorizing those rules, but will call for changes to find savings elsewhere in the program.

The Obama administration's push to transform the way the US pays for healthcare is splitting the medical profession, as family doctors embrace changes that oncologists, neurologists and other specialists are concerned will cause turmoil.

Multiplexed genetic screening for EGFR and ALK gene rearrangements and subsequent biomarker-guided treatment is cost-effective compared with standard chemotherapy treatment without any molecular testing in the metastatic NSCLC setting in the United States, researchers report in The Journal of Thoracic Oncology.

With 3 I-O agents have already been approved for metastatic melanoma, 2 from BMS and 1 from Merck, the race for NSCLC has tightened with multiple ongoing clinical trials.

Companies including Google, Twitter, Yahoo and Advertising.com automatically obtain information from people visiting HealthCare.gov, according to analysis by congressional staffers.

Supporters of the Affordable Care Act worry that the tax-filing season will generate new anger as uninsured consumers learn that they must pay tax penalties.

Addressing primary medication nonadherence through a telephonic intervention from the physicians office was not any more successful than the usual phone calls from the pharmacy.

Insurers and state Medicaid agencies have been eager to strike a deal with pharmaceutical companies to secure discounts on pricey hepatitis C drugs.

New reports show that 2 big experiments run by the health law's innovation lab delivered mixed early results in enhancing primary care.

Although one of the central features of the Affordable Care Act was eliminating discrimination based on preexisting conditions, there is evidence insurers have found ways to dissuade high-cost patients from enrolling in their plans.

Lawmakers in Wyoming are working toward an agreement that would allow the state to accept hundreds of millions of federal dollars to expand the state's Medicaid program.

A one-minute look back at the week of January 26, 2015, in managed care, including anticipated moves from volume-based to value-based payments and expected push back on cancer drug costs.

California advocates worry that having half its children in Medi-Cal will mean poor access to care. But the real issue may be the growing number of poor children nationwide and the overall effect on Medicaid.

Reports say NIH would receive funds to collect DNA from 1 million volunteers, the National Cancer Institute would get research funds, and FDA would get support to regulate molecular diagnostic tests. The plans need funding from Congress.

The Canadian company Valeant Pharmaceuticals International Inc has reached an agreement to buy the prostate cancer immunotherapy from Dendreon Corp.

The integrated cancer services offered by Sarah Cannon will soon be supported by the personalized medicine technology platform of Syapse, to improve individualized patient care, the companies have announced.

The Office of the National Coordinator for Health Information Technology has released the first draft of its interoperability roadmap to deliver better care through the exchange and use of health information technology.

The CDC report found that patients on high cost prescription medications ask their physician for low-cost alternatives, but cheaper medications from outside the Unites States, skip doses, or delay refills to save cost.

Mobile health (mHealth) can be so much more than smartphone apps, and it is a growing movement in the United States that can empower patients, providers, and payers, according to Meg Maley, RN, BSN, founder and CEO of CanSurround.